Helixmith Co., Ltd.

This study aimed to test the safety of injecting a gene therapy called VM202 directly into the heart muscle of people with severe, untreatable chest pain due to blocked arteries. The trial was withdrawn before enrolling any participants, so no results are available. The goal was …

This study aimed to test a new gene therapy called VM202RY, injected directly into the heart, to see if it could safely improve heart function in people who recently had a heart attack. The study was planned for adults aged 19 to 75 with reduced heart pumping ability. However, th…

This study aimed to see if adding TADIOS to standard care helps people with mild to moderate COVID-19 recover faster and feel better. Researchers planned to measure inflammation markers, symptom improvement, and quality of life in hospitalized adults aged 18-65. However, the stud…

This study aimed to test a gene therapy for X-linked chronic granulomatous disease (CGD), a rare immune disorder that makes patients prone to severe infections. The treatment involved taking the patient's own blood stem cells, adding a corrected gene, and returning them to the bo…

This study aimed to see if the herbal tablet PG201 could reduce pain and improve function in people with knee osteoarthritis. It planned to enroll adults aged 40 to 75 and compare different doses against a placebo over 8 weeks. However, the study was withdrawn before any particip…